258 related articles for article (PubMed ID: 18806312)
1. NTPDase and 5'-nucleotidase activities in physiological and disease conditions: new perspectives for human health.
Schetinger MR; Morsch VM; Bonan CD; Wyse AT
Biofactors; 2007; 31(2):77-98. PubMed ID: 18806312
[TBL] [Abstract][Full Text] [Related]
2. Enzymes that hydrolyze adenine nucleotides in lymphocytes and platelets of immunosuppressed rats.
Saucedo EM; Pereira RS; Barbosa GM; Battisti V; Leal CA; Fleck J; Santos RC; Morsch VM; Schetinger MR; Leal DB
Biomed Pharmacother; 2010 Jul; 64(6):437-40. PubMed ID: 20359849
[TBL] [Abstract][Full Text] [Related]
3. Effect of high glucose levels in human platelet NTPDase and 5'-nucleotidase activities.
Lunkes GI; Lunkes DS; Leal D; Araújo Mdo C; Corrêa M; Becker L; Rosa CS; Morsch VM; Schetinger MR
Diabetes Res Clin Pract; 2008 Sep; 81(3):351-7. PubMed ID: 18644642
[TBL] [Abstract][Full Text] [Related]
4. The effects of angiotensin II and genetic hypertension upon extracellular nucleotide hydrolysis by rat platelet ectoenzymes.
Fürstenau CR; Trentin DS; Barreto-Chaves ML; Sarkis JJ
Thromb Res; 2007; 120(6):877-84. PubMed ID: 17343900
[TBL] [Abstract][Full Text] [Related]
5. Altered E-NTPDase/E-ADA activities and CD39 expression in platelets of sickle cell anemia patients.
Castilhos LG; Doleski PH; Adefegha SA; Becker LV; Ruchel JB; Leal DB
Biomed Pharmacother; 2016 Apr; 79():241-6. PubMed ID: 27044834
[TBL] [Abstract][Full Text] [Related]
6. NTPDase and 5'-nucleotidase activities in rats with alloxan-induced diabetes.
Lunkes GI; Lunkes DS; Morsch VM; Mazzanti CM; Morsch AL; Miron VR; Schetinger MR
Diabetes Res Clin Pract; 2004 Jul; 65(1):1-6. PubMed ID: 15163471
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic potentials of ecto-nucleoside triphosphate diphosphohydrolase, ecto-nucleotide pyrophosphatase/phosphodiesterase, ecto-5'-nucleotidase, and alkaline phosphatase inhibitors.
al-Rashida M; Iqbal J
Med Res Rev; 2014 Jul; 34(4):703-43. PubMed ID: 24115166
[TBL] [Abstract][Full Text] [Related]
8. Role of Ectonucleotidases in Synapse Formation During Brain Development: Physiological and Pathological Implications.
Grković I; Drakulić D; Martinović J; Mitrović N
Curr Neuropharmacol; 2019; 17(1):84-98. PubMed ID: 28521702
[TBL] [Abstract][Full Text] [Related]
9. Trichomonas vaginalis NTPDase and ecto-5'-nucleotidase hydrolyze guanine nucleotides and increase extracellular guanosine levels under serum restriction.
Menezes CB; Durgante J; de Oliveira RR; Dos Santos VH; Rodrigues LF; Garcia SC; Dos Santos O; Tasca T
Mol Biochem Parasitol; 2016 May; 207(1):10-8. PubMed ID: 27150347
[TBL] [Abstract][Full Text] [Related]
10. Contribution of ecto-5'-nucleotidase to the inhibition of platelet aggregation by human endothelial cells.
Kawashima Y; Nagasawa T; Ninomiya H
Blood; 2000 Sep; 96(6):2157-62. PubMed ID: 10979961
[TBL] [Abstract][Full Text] [Related]
11. NTPDase and 5'-nucleotidase activities in platelets of human pregnants with a normal or high risk for thrombosis.
Leal CA; Schetinger MR; Leal DB; Bauchspiess K; Schrekker CM; Maldonado PA; Morsch VM; da Silva JE
Mol Cell Biochem; 2007 Oct; 304(1-2):325-30. PubMed ID: 17557193
[TBL] [Abstract][Full Text] [Related]
12. Role of extracellular ATP metabolism in regulation of platelet reactivity.
Birk AV; Broekman MJ; Gladek EM; Robertson HD; Drosopoulos JH; Marcus AJ; Szeto HH
J Lab Clin Med; 2002 Sep; 140(3):166-75. PubMed ID: 12271274
[TBL] [Abstract][Full Text] [Related]
13. Extracellular ATP metabolism on vascular endothelial cells: A pathway with pro-thrombotic and anti-thrombotic molecules.
Fuentes E; Palomo I
Vascul Pharmacol; 2015 Dec; 75():1-6. PubMed ID: 25989108
[TBL] [Abstract][Full Text] [Related]
14. Ectonucleotidases and nucleotide/nucleoside transporters as pharmacological targets for neurological disorders.
Bonan CD
CNS Neurol Disord Drug Targets; 2012 Sep; 11(6):739-50. PubMed ID: 22963442
[TBL] [Abstract][Full Text] [Related]
15. The impact of purinergic signaling on renal ischemia-reperfusion injury.
Lu B; Rajakumar SV; Robson SC; Lee EK; Crikis S; d'Apice AJ; Cowan PJ; Dwyer KM
Transplantation; 2008 Dec; 86(12):1707-12. PubMed ID: 19104409
[TBL] [Abstract][Full Text] [Related]
16. Structural and functional characterization of engineered bifunctional fusion proteins of CD39 and CD73 ectonucleotidases.
Zhong EH; Ledderose C; De Andrade Mello P; Enjyoji K; Lunderberg JM; Junger W; Robson SC
Am J Physiol Cell Physiol; 2021 Jan; 320(1):C15-C29. PubMed ID: 33052071
[TBL] [Abstract][Full Text] [Related]
17. Ecto-nucleotidases of the CD39/NTPDase family modulate platelet activation and thrombus formation: Potential as therapeutic targets.
Atkinson B; Dwyer K; Enjyoji K; Robson SC
Blood Cells Mol Dis; 2006; 36(2):217-22. PubMed ID: 16476557
[TBL] [Abstract][Full Text] [Related]
18. New insights into molecular structure and function of ectonucleotidases in the nervous system.
Zimmermann H; Braun N; Kegel B; Heine P
Neurochem Int; 1998; 32(5-6):421-5. PubMed ID: 9676740
[TBL] [Abstract][Full Text] [Related]
19. Beyond ecto-nucleotidase: CD39 defines human Th17 cells with CD161.
Bai A; Robson S
Purinergic Signal; 2015 Sep; 11(3):317-9. PubMed ID: 26059452
[TBL] [Abstract][Full Text] [Related]
20. Ectonucleotidases in Blood Malignancies: A Tale of Surface Markers and Therapeutic Targets.
Vaisitti T; Arruga F; Guerra G; Deaglio S
Front Immunol; 2019; 10():2301. PubMed ID: 31636635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
